David A. Gonyer's most recent trade in Evoke Pharma Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc | David A. Gonyer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) |